YOLFTbeta
30

Yipinhong Pharmaceutical Co Ltd Class A

300723 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

28.25CNY-0.96 (-3.29%)

Price History

Full chart

Market Stats

Previous Close29.21
Open29.25
Day Range28.13 – 29.41
52-Week Range29.31 – 62.50
Volume2.90M
Market Cap15.03B
P/E (TTM)67.90
Forward P/E0.00
EPS0.49
Dividend Yield0.00%
Beta0.77
50-Day Avg35.55
200-Day Avg36.02

About

ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers pediatric medicines; chronic disease drugs; active pharmaceutical ingredients and formulations; and specialty traditional Chinese medicines. It is also involved in scientific research and technical services; wholesale and retail trade; information technology; and technology promotion and application services. The company was formerly known as ApicHope Pharmaceutical Co., Ltd and changed its name to ApicHope Pharmaceutical Group Co., Ltd. in December 2024. ApicHope Pharmaceutical Group Co., Ltd. was founded in 2002 and is headquartered in Guangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Hanxiong Li
  • Employees1.29K
  • HeadquartersYunrun Building, Guangzhou, China, 510320, China
  • Websitehttps://www.apichope.com

Leadership

  • Mr. Hanxiong LiChairman of the Board of Directors & GM · b. 1974
  • Mr. Huixing ZhangAccounting Supervisor & CFO · b. 1966
  • Ms. Dongling YangDeputy GM & Non-Independent Director · b. 1967
  • Mr. Mingyuan ZhangDeputy GM & Secretary of Board · b. 1985

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue507.57M792.55M1.03B1.25B1.38B1.43B1.64B1.68B2.20B2.28B2.50B1.45B932.27M
Growth (%)-+56.15%+29.74%+21.64%+10.34%+3.57%+14.54%+2.32%+31.26%+3.68%+9.79%-42.07%-35.72%
Cost of Revenue316.61M391.44M478.77M600.77M583.28M395.85M369.56M297.66M321.98M300.20M481.98M576.21M405.76M
Gross Profit190.95M401.12M549.53M650.06M796.94M1.03B1.27B1.38B1.88B1.98B2.02B874.02M526.52M
Gross Margin37.62%50.61%53.44%51.97%57.74%72.31%77.43%82.23%85.36%86.83%80.75%60.27%56.48%
Operating Expense147.24M348.26M468.71M508.26M615.24M798.88M1.09B1.18B1.59B1.70B1.81B1.24B776.68M
Operating Income43.71M52.86M80.82M141.80M181.70M234.83M182.27M198.55M285.28M281.97M213.93M-370.71M-250.16M
Operating Margin8.61%6.67%7.86%11.34%13.16%16.43%11.13%11.85%12.97%12.37%8.55%-25.56%-26.83%
EBITDA65.43M91.20M130.89M190.86M221.58M252.91M202.32M225.05M305.79M366.46M387.34M-115.53M-96.68M
EBITDA Margin12.89%11.51%12.73%15.26%16.05%17.69%12.36%13.43%13.90%16.07%15.47%-7.97%-10.37%
Net Income32.99M40.31M60.42M137.35M156.70M208.22M143.69M225.61M306.92M290.68M184.61M-540.04M-337.79M
Net Income Margin6.50%5.09%5.88%10.98%11.35%14.57%8.78%13.47%13.96%12.75%7.37%-37.24%-36.23%
R&D18.49M40.32M43.07M46.97M81.07M91.38M98.05M135.34M142.32M189.78M301.37M312.09M157.25M
R&D as % of Total Revenue3.64%5.09%4.19%3.75%5.87%6.39%5.99%8.08%6.47%8.32%12.04%21.52%16.87%
Interest Expense6.97M20.68M32.53M18.37M15.57M17.52M5.56M12.03M45.20M30.27M37.65M36.40M57.79M
Interest Expense % of Total Revenue1.37%2.61%3.16%1.47%1.13%1.23%0.34%0.72%2.06%1.33%1.50%2.51%6.20%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets411.27M733.80M630.56M752.32M1.48B1.78B1.79B2.15B3.70B4.10B4.41B4.40B4.04B
Total Liabilities225.66M606.28M429.90M415.82M373.45M481.67M454.20M650.14M1.69B1.93B1.81B2.47B2.64B
Total Equity177.21M127.52M195.88M333.23M1.11B1.30B1.33B1.48B1.87B2.05B2.52B1.88B1.37B
Cash28.79M37.40M29.78M94.25M85.04M751.60M710.21M726.03M1.08B645.60M422.52M468.97M515.38M
Total Debt79.55M396.43M355.92M318.71M250.88M279.34M197.60M290.04M1.23B1.17B736.03M1.61B-
Net Debt50.76M359.04M326.14M224.46M165.84M-472.26M-512.61M-435.99M154.04M522.06M313.51M1.14B1.37B

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow135.68M8.74M34.55M146.01M141.35M238.60M280.65M275.22M438.10M475.53M458.05M-550.42M46.01M
Investing Cash Flow-114.32M-266.23M145.21M-28.38M-698.46M408.45M-117.69M-307.17M-919.59M-669.53M-578.99M-275.00M-
Financing Cash Flow-40.21M267.65M-183.62M-55.65M550.78M19.88M-209.37M16.78M555.81M-138.90M99.76M816.00M-
Capital Expenditure87.58M112.21M42.33M28.55M28.49M256.77M105.22M314.15M561.23M605.78M334.46M319.76M127.21M
Free Cash Flow48.10M-103.47M-7.78M117.46M112.86M-18.17M175.43M-38.93M-123.13M-130.25M123.59M-870.18M-81.19M
Dividends Paid7.16M20.53M147.91M18.44M15.58M41.39M32.18M31.41M39.26M56.60M56.63M108.21M56.84M
FCF to OCF35.45%-1183.59%-22.51%80.44%79.85%-7.61%62.51%-14.15%-28.11%-27.39%26.98%158.09%-176.46%
Dividend Paid to FCF14.88%-19.85%-1901.87%15.70%13.80%-227.79%18.34%-80.68%-31.89%-43.45%45.82%-12.44%-70.00%

Earnings

Report DateDec 31, 2017Apr 23, 2018Aug 23, 2018Oct 26, 2018Mar 13, 2019Apr 30, 2019Aug 12, 2019Oct 22, 2019Dec 31, 2019Apr 21, 2020Aug 27, 2020Oct 29, 2020Mar 29, 2021Apr 12, 2021Jul 29, 2021Oct 21, 2021Mar 31, 2022Apr 20, 2022Jul 28, 2022Oct 19, 2022Dec 31, 2022Apr 19, 2023Aug 29, 2023Oct 26, 2023Feb 1, 2024Apr 26, 2024Jun 30, 2024Oct 29, 2024Dec 31, 2024Apr 24, 2025Aug 22, 2025Oct 31, 2025Apr 27, 2026Aug 27, 2026
EPS Estimate----------------------------------
EPS Actual0.110.130.130.180.280.170.200.21-0.06-0.080.130.400.180.240.180.590.070.070.260.390.060.090.220.17-0.210.22-0.12-0.65-0.660.13-0.29-0.141.33-0.24
Surprise----------------------------------
Timing-After-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hours-Pre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-marketAfter-hoursPre-market-Pre-market-After-hours----

Key Statistics & Ratios

Market Cap15.03B
Enterprise Value16.33B
Trailing P/E67.90
Forward P/E0.00
Price / Sales17.89
Price / Book8.41
EPS0.49
Book Value4.11
Revenue (TTM)840.19M
Gross Profit (TTM)457.69M
EBITDA-134.69M
Profit Margin26.24%
Operating Margin-136.23%
Return on Equity11.38%
Return on Assets-4.27%
Shares Outstanding451.69M
Shares Float160.07M
Beta0.77
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.21Jun 3, 2024
20231×
0.20May 24, 2023
20221×
0.13May 25, 2022
20211×
0.09Apr 29, 2021
20201×
0.07Jun 4, 2020
20191×
0.07Apr 26, 2019
20181×
0.06May 25, 2018

Stock Splits

  • May 24, 20231.5:1
  • Apr 29, 20211.8:1